ACADAcadia Pharmaceuticals Inc
$25.09
$0.03
(0.12%)
Closed $25.60
$0.51
(1.99%)
After Hours
EarningsAug 4
Mkt Cap$4.39B
Vol1.21M
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, after the close of the U.S. financial markets. Acadias management team will also host a conference call and webcast on August 4, 2026, at 4:30 p.m...
Business Wire
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
Key PointsPrincipal Accounting Officer James Kihara sold 11,421 shares for a transaction value of approximately ~$298,000 on June 26, 2026...
Nasdaq News: Markets
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
Verastem (VSTM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
RPRX or ACAD: Which Is the Better Value Stock Right Now?
RPRX vs. ACAD: Which Stock Is the Better Value Option?
Zacks
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Carl Segerstrom as Chief People Officer, effective July 6. Carl will lead the companys global people and culture strategy, supporting its next phase of growth as a leading neurological and rare disease company focused on...
Business Wire
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome
Acadia stock jumps 7% as CHMP backs Daybu for EU approval in Rett syndrome, with the European Commission set to make a final decision in the coming months.
Zacks
Strength Seen in Acadia (ACAD): Can Its 6.8% Jump Turn into More Strength?
Acadia (ACAD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Why Acadia Pharmaceuticals Stock Is Soaring Today
Why Acadia Pharmaceuticals Stock Is Soaring Today...
Yahoo! Finance: News
Apogee Enterprises Posts Strong Q1 Earnings, Joins ACADIA Pharmaceuticals, Crocs And Other Big Stocks Moving Higher On Friday
Apogee Enterprises Inc (NASDAQ: APOG) rose sharply after the company reported better-than-expected first-quarter financial results. Other big gainers in today's session include FuelCell Energy Inc (NASDAQ: FCEL) up 17.6%, BitVentures Limited (NASDAQ: BVC) up 14.1%, and ACADIA Pharmaceuticals Inc...
Benzinga
<
1
2
...
>
Advertisement|Remove ads.
Latest ACAD News
ViewAcadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
Business Wire
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
Nasdaq News: Markets
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
Zacks
SPY15
34
SG2
1
NFLX20
28Advertisement|Remove ads.